Abbvie to partner with Genmab in $750 million cancer therapy deal
[ad_1] FILE PHOTO: A screen displays the share price for drugmaker AbbVie on the floor of the New York Stock
Read more
Genmab
[ad_1] FILE PHOTO: A screen displays the share price for drugmaker AbbVie on the floor of the New York Stock
Read more